|
1
|
Morrow JJ and Khanna C: Osteosarcoma
genetics and epigenetics: Emerging biology and candidate therapies.
Crit Rev Oncog. 20:173–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hattinger CM, Fanelli M, Tavanti E, Vella
S, Ferrari S, Picci P and Serra M: Advances in emerging drugs for
osteosarcoma. Expert Opin Emerg Drugs. 20:495–514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin JW, Squire JA and Zielenska M: The
genetics of osteosarcoma. Sarcoma. 2012:6272542012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luco RF, Pan Q, Tominaga K, Blencowe BJ,
Pereira-Smith OM and Misteli T: Regulation of alternative splicing
by histone modifications. Science. 327:996–1000. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huertas D, Sendra R and Muñoz P: Chromatin
dynamics coupled to DNA repair. Epigenetics. 4:31–42. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greer EL and Shi Y: Histone methylation: A
dynamic mark in health, disease and inheritance. Nat Rev Genet.
13:343–357. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hamamoto R, Saloura V and Nakamura Y:
Critical roles of non-histone protein lysine methylation in human
tumorigenesis. Nat Rev Cancer. 15:110–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balakrishnan L and Milavetz B: Decoding
the histone H4 lysine 20 methylation mark. Crit Rev Biochem Mol
Biol. 45:440–452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jorgensen S, Schotta G and Sorensen CS:
Histone H4 lysine 20 methylation: Key player in epigenetic
regulation of genomic integrity. Nucleic Acids Res. 41:2797–2806.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kwon MJ, Kim SS, Choi YL, Jung HS, Balch
C, Kim SH, Song YS, Marquez VE, Nephew KP and Shin YK: Derepression
of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with
loss of repressive histone modifications. Carcinogenesis.
31:974–983. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fraga MF, Ballestar E, Villar-Garea A,
Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S,
Petrie K, et al: Loss of acetylation at Lys16 and trimethylation at
Lys20 of histone H4 is a common hallmark of human cancer. Nat
Genet. 37:391–400. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pogribny IP, Ross SA, Tryndyak VP,
Pogribna M, Poirier LA and Karpinets TV: Histone H3 lysine 9 and H4
lysine 20 trimethylation and the expression of Suv4-20h2 and
Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced
by methyl deficiency in rats. Carcinogenesis. 27:1180–1186. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tryndyak VP, Kovalchuk O and Pogribny IP:
Loss of DNA methylation and histone H4 lysine 20 trimethylation in
human breast cancer cells is associated with aberrant expression of
DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and
methyl-binding proteins. Cancer Biol Ther. 5:65–70. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van Den Broeck A, Brambilla E,
Moro-Sibilot D, Lantuejoul S, Brambilla C, Eymin B and Gazzeri S:
Loss of histone H4K20 trimethylation occurs in preneoplasia and
influences prognosis of non-small cell lung cancer. Clin Cancer
Res. 14:7237–7245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schneider AC, Heukamp LC, Rogenhofer S,
Fechner G, Bastian PJ, von Ruecker A, Müller SC and Ellinger J:
Global histone H4K20 trimethylation predicts cancer-specific
survival in patients with muscle-invasive bladder cancer. BJU Int.
108:E290–E296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benard A, Goossens-Beumer IJ, van Hoesel
AQ, de Graaf W, Horati H, Putter H, Zeestraten EC, van de Velde CJ
and Kuppen PJ: Histone trimethylation at H3K4, H3K9 and H4K20
correlates with patient survival and tumor recurrence in
early-stage colon cancer. BMC Cancer. 14:5312014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yokoyama Y, Matsumoto A, Hieda M, Shinchi
Y, Ogihara E, Hamada M, Nishioka Y, Kimura H, Yoshidome K,
Tsujimoto M and Matsuura N: Loss of histone H4K20 trimethylation
predicts poor prognosis in breast cancer and is associated with
invasive activity. Breast Cancer Res. 16:R662014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paydar P, Asadikaram G, Nejad HZ, Akbari
H, Abolhassani M, Moazed V, Nematollahi MH, Ebrahimi G and Fallah
H: Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4
and H3 are associated with breast tumors. J Cell Biochem.
120:13726–13736. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y, Shi W, Tang T, Wang Y, Yin X, Chen
Y, Zhang Y, Xing Y, Shen Y, Xia T, et al: miR-29a contributes to
breast cancer cells epithelial-mesenchymal transition, migration,
and invasion via down-regulating histone H4K20 trimethylation
through directly targeting SUV420H2. Cell Death Dis. 10:1762019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Özgür E, Keskin M, Yörüker EE,
Holdenrieder S and Gezer U: Plasma histone H4 and H4K20
trimethylation levels differ between colon cancer and precancerous
polyps. In vivo. 33:1653–1658. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang H, Pesavento JJ, Starnes TW,
Cryderman DE, Wallrath LL, Kelleher NL and Mizzen CA: Preferential
dimethylation of histone H4 lysine 20 by Suv4-20. J Biol Chem.
283:12085–12092. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakaguchi A, Karachentsev D, Seth-Pasricha
M, Druzhinina M and Steward R: Functional characterization of the
Drosophila Hmt4-20/Suv4-20 histone methyltransferase. Genetics.
179:317–322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schotta G, Sengupta R, Kubicek S, Malin S,
Kauer M, Callén E, Celeste A, Pagani M, Opravil S, De La
Rosa-Velazquez IA, et al: A chromatin-wide transition to H4K20
monomethylation impairs genome integrity and programmed DNA
rearrangements in the mouse. Genes Dev. 22:2048–2061. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benetti R, Gonzalo S, Jaco I, Schotta G,
Klatt P, Jenuwein T and Blasco MA: Suv4-20h deficiency results in
telomere elongation and derepression of telomere recombination. J
Cell Biol. 178:925–936. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marion RM, Schotta G, Ortega S and Blasco
MA: Suv4-20h abrogation enhances telomere elongation during
reprogramming and confers a higher tumorigenic potential to iPS
cells. PLoS One. 6:e256802011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trapnell C, Roberts A, Goff L, Pertea G,
Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L:
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tian L, Greenberg SA, Kong SW, Altschuler
J, Kohane IS and Park PJ: Discovering statistically significant
pathways in expression profiling studies. Proc Natl Acad Sci USA.
102:13544–13549. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eferl R and Wagner EF: AP-1: A
double-edged sword in tumorigenesis. Nat Rev Cancer. 3:859–868.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Strelau J, Bottner M, Lingor P,
Suter-Crazzolara C, Galter D, Jaszai J, Sullivan A, Schober A,
Krieglstein K and Unsicker K: GDF-15/MIC-1 a novel member of the
TGF-beta superfamily. Journal of neural transmission. J Neural
Transm Suppl. 273–276. 2000.PubMed/NCBI
|
|
31
|
Strahl BD and Allis CD: The language of
covalent histone modifications. Nature. 403:41–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kouzarides T: Chromatin modifications and
their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schotta G, Lachner M, Sarma K, Ebert A,
Sengupta R, Reuter G, Reinberg D and Jenuwein T: A silencing
pathway to induce H3-K9 and H4-K20 trimethylation at constitutive
heterochromatin. Genes Dev. 18:1251–1262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shinchi Y, Hieda M, Nishioka Y, Matsumoto
A, Yokoyama Y, Kimura H, Matsuura S and Matsuura N: SUV420H2
suppresses breast cancer cell invasion through down regulation of
the SH2 domain-containing focal adhesion protein tensin-3. Exp Cell
Res. 334:90–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khani F, Thaler R, Paradise CR, Deyle DR,
Kruijthof-de Julio M, Galindo M, Gordon JA, Stein GS, Dudakovic A
and van Wijnen AJ: Histone H4 methyltransferase Suv420h2 maintains
fidelity of osteoblast differentiation. J Cell Biochem.
118:1262–1272. 2017. View Article : Google Scholar : PubMed/NCBI
|
